# Effects of Medical Cannabis Treatment for Autistic Children on Family Accommodation: An Open-Label Mixed-Methods Study

**Authors:** Ayelet David, Eynat Gal, Ayelet Ben-Sasson, Elkana Kohn, Matitiahu Berkovitch, Orit Stolar

PMC · DOI: 10.3390/children12101373 · 2025-10-11

## TL;DR

CBD-rich cannabis treatment over six months may reduce family adjustments and parental stress in families of autistic children, while improving routines and well-being.

## Contribution

Preliminary evidence that CBD-rich cannabis treatment can reduce family accommodation and parental distress in autistic children's families.

## Key findings

- CBD-rich cannabis treatment was associated with reduced family accommodation and parental distress over six months.
- Qualitative results showed improved family routines, parental well-being, and social engagement.
- Adverse events and withdrawals were observed, suggesting caution in interpreting the findings.

## Abstract

What are the main findings?
CBD-rich cannabis treatment over 6 months was associated with reduced family accommodation (FA) and parental distress in families of autistic children.Qualitative findings showed improved family routines, parental well-being, and greater engagement in meaningful activities and social interactions.

CBD-rich cannabis treatment over 6 months was associated with reduced family accommodation (FA) and parental distress in families of autistic children.

Qualitative findings showed improved family routines, parental well-being, and greater engagement in meaningful activities and social interactions.

Implications
CBD-rich cannabis treatment may reduce FA and parental distress, while improving family routines and well-being.These results provide preliminary support for CBD-rich cannabis treatment in autistic children, though further controlled studies are needed.

CBD-rich cannabis treatment may reduce FA and parental distress, while improving family routines and well-being.

These results provide preliminary support for CBD-rich cannabis treatment in autistic children, though further controlled studies are needed.

Background/Objectives: Parents of autistic children often face behavioral and participation challenges of their children, leading them to make accommodations to maintain a stable daily family routine. These family accommodations (FA) involve adapting family routines, actively engaging with the child’s support needs and symptoms, and avoiding specific situations. Methods: This open-label, mixed-methods study investigated the impact of CBD-rich cannabis treatment on FA. In the quantitative phase, analyses included 44 parents (from 87 initially recruited) who had complete FAS-RRB data at baseline, 3 months, and 6 months. In the following qualitative phase, 15 parents from the full sample participated in semi-structured interviews. Results: Quantitative results showed reductions in FA frequency and parental distress at 3 and 6 months. Qualitative findings revealed positive changes in family routines, enhanced well-being, and improved parental engagement in meaningful activities and social interactions. Conclusions: This study provides preliminary evidence that CBD-rich cannabis treatment may reduce family accommodation (FA) and parental distress, while improving family routines and well-being. However, given the open-label design and observed adverse events and withdrawals, the findings should be interpreted with caution.

## Linked entities

- **Chemicals:** CBD (PubChem CID 644019)
- **Diseases:** autism (MONDO:0005260)

## Full-text entities

- **Genes:** FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}
- **Diseases:** Autistic (MESH:D001321)
- **Chemicals:** CBD (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12563248/full.md

---
Source: https://tomesphere.com/paper/PMC12563248